HymonBio’s Booth Remains Popular on Day 2 of the 2025 Medical Device Innovation Exhibition

News

HymonBio’s Booth Remains Popular on Day 2 of the 2025 Medical Device Innovation Exhibition

Live from the Exhibition

The Medical Device Innovation Exhibition enters its second day on August 22, and HymonBio’s booth remained popular. Many visitors, having heard the presentation yesterday, returned with their companions, hoping to learn more about the product.

Inquiries were flowing in front of the booth, and staff patiently answered questions about the Pan-Cancer Screening Test Kit’s testing process and recommended populations. The atmosphere was lively and engaging.

Weixin Image_20250902101625

During Chinese and English product presentations, representatives introduced their star product, the Pan-Cancer Screening Test Kit, successfully attracting a delegation composed of scholars from top university research institutes in South Korea and experts from well-known hospitals to stop and exchange ideas.

Exclusive Interview

This afternoon (August 22nd), Dr. Tammy Tan, Chairman of HymonBio, gave an exclusive interview to MEDICARE Studio.

In the interview, Dr. Tan shared her company’s latest breakthroughs in cancer pathogenesis research and emerging infectious diseases molecular diagnostics. She also detailed the company’s core technology platform and representative products, such as the Pan-Cancer Screening Test Kit. She analyzed innovative products on display and their unique advantages in clinical application and market competitiveness, as well as outlined the company’s strategic layout and expansion plans into new scenarios in the fields of early cancer screening, molecular diagnostics, and public health prevention and control.

Weixin Image_20250902101923 Weixin Image_20250902101925

Tomorrow is the last day of the exhibition.

HymonBio is waiting for you at booth B1D18!


Post time: Aug-22-2025